[Summary] 眼科领域的创新药研发商
若见辉瞳成立于2025年,是一家聚焦于眼科领域的创新药研发公司。公司目前重点在研两条核心产品管线均为firstin的创新药,拥有全球专利,临床申报路径为FDANMPA双报,并开展了大量的IT研究。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows